Several studies have assessed the potentially increased rate and the management of osteoporotic and fragility fractures during the COVID-19 pandemic.
History of obstructive sleep apnea (OSA) is independently associated with a higher risk for confirmed vertebral fracture.
Researchers assessed the association between concomitant use of oral glucocorticoids and proton pump inhibitors and osteoporotic fracture risk in rheumatoid arthritis.
Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.
Researchers evaluated the association between risk for atypical fracture and duration of bisphosphonate use in women with osteoporosis.
The use of sodium-glucose transporter-2 inhibitors combined with metformin did not affect fracture risk in T2D.
Researchers estimated risk for fracture among patients receiving denosumab with delayed subsequent doses vs those who received doses on time.
In patients who have previously suffered a vertebral fracture, a longer bisphosphonate drug holiday is associated with an increased risk for major osteoporotic fractures.
In this systematic review, the study authors evaluated the current evidence on orthogeriatric care for older patients with hip fracture.
The incidence of hip fracture decreased from 1970 to 2010 in the US.
